Rajan Sharma
Stock Analyst at Goldman Sachs
(0.40)
# 2,936
Out of 4,479 analysts
6
Total ratings
50%
Success rate
-17.67%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZN AstraZeneca | Initiates: Buy | $97 | $76.99 | +25.99% | 1 | May 30, 2024 | |
| GSK GSK | Initiates: Neutral | $47 | $38.21 | +23.00% | 1 | May 30, 2024 | |
| MOR MorphoSys AG | Maintains: Neutral | $9.25 → $4.75 | $18.10 | -73.76% | 2 | Nov 22, 2023 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $34.80 | +127.01% | 2 | Jun 20, 2023 |
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $76.99
Upside: +25.99%
GSK
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $38.21
Upside: +23.00%
MorphoSys AG
Nov 22, 2023
Maintains: Neutral
Price Target: $9.25 → $4.75
Current: $18.10
Upside: -73.76%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $34.80
Upside: +127.01%